Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Ascent Pharmaceuticals, Inc. Patents
Assignee:
Ascent Pharmaceuticals, Inc.
Address:
Billerica, MA
No. of patents:
8
Patents:












Patent Number Title Of Patent Date Issued
5684038 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5684037 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea November 4, 1997
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5672358 Controlled release aqueous emulsion September 30, 1997
A controlled release aqueous emulsion is disclosed, as are its method of manufacture and use as a vehicle for delivering medicaments in liquid form. A contemplated emulsion comprises an oil-in-water emulsion having an average oil particle size of about 100 nm to about 250 nm, a pH value
5626879 Terfenadine oral granules May 6, 1997
The present invention contemplates a dry, granular terfenadine composition. That composition comprises (i) particulate terfenadine and (ii) a polyethylene oxide-polypropylene oxide-polyethylene oxide block copolymer having an HLB number of 24 that is a wetting agent for the terfenadine
5576346 Process for treating uremic pruritus November 19, 1996
A process and pharmaceutical composition for treatment of uremic pruritus in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or disper
5552436 Process for treating hemangioma September 3, 1996
A process and pharmaceutical composition for treatment of hemangioma in humans is disclosed. The pharmaceutical composition comprises a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amide thereof: ##STR1## dissolved or dispersed in a
5532270 Composition and process for prevention and treatment of cutaneous immediate hypersensitivity rea July 2, 1996
A process and pharmaceutical composition for the prevention and treatment of cutaneous Type I hypersensitivity reactions in humans is disclosed. The pharmaceutical composition comprises of a chromone compound of the following formula, or a pharmacologically acceptable salt, ester or amid
5455049 Terfenadine oral powder October 3, 1995
The present invention contemplates a dry, powdered terfenadine composition. That composition comprises(a) a mixture of:(i) about 1 to about 20 parts by weight micronized terfenadine and(ii) about 0.2 to about 10 parts by weight a polyethylene oxide-polypropylene oxide-polyethylene oxide bloc

 
 
  Recently Added Patents
Systems and methods for restoring images
System for highlighting targets on head up displays with near focus plane
Chip on chip semiconductor device including an underfill layer having a resin containing an amine-based curing agent
Methods and compositions for inhibition of neutrophil exocytosis
Illumination apparatus
Methods of measuring cell viability in tissue engineered products
Hypallergenic mosaic antigens and methods of making same
  Randomly Featured Patents
Methods of encoding payload bits for transmission
Coffee machine
Mobile phone
Soft inplane bearingless helicopter rotor
Asynchronous enhanced shared secret provisioning protocol
Method and system for adaptive component placement
Optical scanning for record carriers adapted for reading with differing wavelengths
Method for conjugating to polyamino compounds employing haloacyl groups and compositions prepared thereby
Vibration isolation within disk drive testing systems
Process for the preparation of 2-chlorosulfinylazetidinone